000 | 01901 a2200565 4500 | ||
---|---|---|---|
005 | 20250517202854.0 | ||
264 | 0 | _c20191125 | |
008 | 201911s 0 0 eng d | ||
022 | _a1365-2133 | ||
024 | 7 |
_a10.1111/bjd.16490 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBegon, E | |
245 | 0 | 0 |
_aSafety and efficacy of biological therapies in patients with psoriasis with alcoholic cirrhosis: a French retrospective study of 23 cases. _h[electronic resource] |
260 |
_bThe British journal of dermatology _c08 2018 |
||
300 |
_a512-513 p. _bdigital |
||
500 | _aPublication Type: Letter; Multicenter Study; Observational Study | ||
650 | 0 | 4 |
_aAdalimumab _xadministration & dosage |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aBiological Products _xadministration & dosage |
650 | 0 | 4 |
_aDermatologic Agents _xadministration & dosage |
650 | 0 | 4 |
_aErysipelas _xepidemiology |
650 | 0 | 4 |
_aEtanercept _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFrance |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInfliximab _xadministration & dosage |
650 | 0 | 4 |
_aLiver _xdrug effects |
650 | 0 | 4 |
_aLiver Cirrhosis, Alcoholic _xcomplications |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPsoriasis _xcomplications |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 |
_aUstekinumab _xadministration & dosage |
700 | 1 | _aBeneton, N | |
700 | 1 | _aPoiraud, C | |
700 | 1 | _aDroitcourt, C | |
700 | 1 | _aJacobzone, C | |
700 | 1 | _aVermersch-Langlin, A | |
700 | 1 | _aDescamps, V | |
700 | 1 | _aPerrot, J L | |
700 | 1 | _aKhemis, A | |
700 | 1 | _aPallure, V | |
700 | 1 | _aFougerousse, A C | |
700 | 1 | _aSigal-Grinberg, M | |
700 | 1 | _aSchmutz, J-L | |
700 | 1 | _aGoujon, C | |
700 | 1 | _aReguiai, Z | |
773 | 0 |
_tThe British journal of dermatology _gvol. 179 _gno. 2 _gp. 512-513 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/bjd.16490 _zAvailable from publisher's website |
999 |
_c28122200 _d28122200 |